Follow-on roundup: CRISPR, Viking, Fate, Molecular Templates

CRISPR Therapeutics AG (NASDAQ:CRSP), Viking Therapeutics Inc. (NASDAQ:VKTX), Fate Therapeutics Inc. (NASDAQ:FATE) and Molecular Templates Inc. (NASDAQ:MTEM) each priced follow-ons late Thursday, raising a total of $545.9 million.

CRISPR raised $200 million through the sale of 4.2 million shares at $47.50 in a

Read the full 428 word article

How to gain access

Continue reading with a
two-week free trial.